| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.66  |
1-year : | 28.9 |
| Resists | First : | 20.26 |
Second : | 24.75 |
| Pivot price | 14.14 |
|||
| Supports | First : | 13 | Second : | 10.81 |
| MAs | MA(5) : | 13.8 |
MA(20) : | 14.7 |
| MA(100) : | 15.8  |
MA(250) : | 0 | |
| MACD | MACD : | -1.7 |
Signal : | -1.8 |
| %K %D | K(14,3) : | 26.9 |
D(3) : | 18.9 |
| RSI | RSI(14): 36.5 |
|||
| 52-week | High : | 30.1 | Low : | 9.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CLPT ] has closed above bottom band by 33.3%. Bollinger Bands are 71.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 14.19 - 14.26 | 14.26 - 14.32 |
| Low: | 13.41 - 13.5 | 13.5 - 13.58 |
| Close: | 13.9 - 14.04 | 14.04 - 14.17 |
Fri, 05 Dec 2025
Can CLPT stock reach $100 price target - Quarterly Trade Report & Fast Moving Stock Watchlists - Newser
Wed, 12 Nov 2025
ClearPoint Neuro: CRO Facility Should Reaccelerate Growth (NASDAQ:CLPT) - Seeking Alpha
Mon, 10 Nov 2025
ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 39% Cheaper Price Remains In Tune With Revenues - simplywall.st
Thu, 06 Nov 2025
ClearPoint Neuro (NASDAQ: CLPT) to acquire IRRAS; $0.5B intracranial bleeding market - Stock Titan
Thu, 06 Nov 2025
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Mon, 03 Nov 2025
Is ClearPoint Neuro (NASDAQ:CLPT) A Risky Investment? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 30 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 7.8 (%) |
| Held by Institutions | 39.9 (%) |
| Shares Short | 2,310 (K) |
| Shares Short P.Month | 2,380 (K) |
| EPS | -0.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.56 |
| Profit Margin | -67.5 % |
| Operating Margin | -59.6 % |
| Return on Assets (ttm) | -28.3 % |
| Return on Equity (ttm) | -103.2 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 0.7 |
| Sales Per Share | 1.15 |
| EBITDA (p.s.) | -0.74 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -16.66 |
| PEG Ratio | 0 |
| Price to Book value | 24.67 |
| Price to Sales | 11.97 |
| Price to Cash Flow | -31.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|